CMS Issues Infection Control Guidance to Protect Patients and Healthcare Workers from Covid-19
Based on CDC guidelines, the guidance will help ensure infection control in a variety of patient settings.
Read MorePosted by | Apr 15, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
Based on CDC guidelines, the guidance will help ensure infection control in a variety of patient settings.
Read MorePosted by | Apr 15, 2020 | Allergy & Autoimmune, Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
No instrumentation or trained personnel would be needed to administer the test or to read the results.
Read MorePosted by | Apr 15, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
CQuentia’s covid-19 assay has received FDA emergency use authorization, and its lab has the capacity to process more than 20,000 samples per month.
Read MorePosted by | Apr 15, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
End-to-end testing enables Fulgent to more efficiently manage the demand it is seeing for both its RT-PCR and next-generation sequencing tests for Covid-19.
Read MorePosted by | Apr 14, 2020 | Emerging & Zoonotic Diseases, Infectious Diseases |
Initially Biodesix is receiving samples for covid-19 testing from local health systems, hospitals, and clinics in Colorado.
Read More